Novel Peritoneal Sclerosis Rat Model Developed by Administration of Bleomycin and Lansoprazole

Int J Mol Sci. 2023 Nov 9;24(22):16108. doi: 10.3390/ijms242216108.

Abstract

In our preliminary experiment, peritoneal sclerosis likely induced by peritoneal dialysis was unexpectedly observed in the livers of rats given bleomycin and lansoprazole. We examined whether this peritoneal thickening around the liver was time-dependently induced by administration of both drugs. Male Wistar rats were injected with bleomycin and/or lansoprazole for 2 or 4 weeks. The 3YB-1 cell line derived from rat fibroblasts was treated by bleomycin and/or lansoprazole for 24 h. The administration of both drugs together, but not individually, thickened the peritoneal tissue around the liver. There was accumulation of collagen fibers, macrophages, and eosinophils under mesothelial cells. Expressions of Col1a1, Mcp1 and Mcp3 genes were increased in the peritoneal tissue around the liver and in 3YB-1 cells by the administration of both drugs together, and Opn genes had increased expressions in this tissue and 3YB-1 cells. Mesothelial cells indicated immunoreactivity against both cytokeratin, a mesothelial cell marker, and αSMA, a fibroblast marker, around the livers of rats given both drugs. Administration of both drugs induced the migration of macrophages and eosinophils and induced fibrosis associated with the possible activation of fibroblasts and the possible promotion of the mesothelial-mesenchymal transition. This might become a novel model of peritoneal sclerosis for peritoneal dialysis.

Keywords: Mcp1; Mcp3; Opn; bleomycin; collagen 1a1; fibrosis; lansoprazole.

MeSH terms

  • Animals
  • Bleomycin / adverse effects
  • Epithelial Cells / metabolism
  • Lansoprazole / adverse effects
  • Lansoprazole / metabolism
  • Male
  • Peritoneal Fibrosis* / chemically induced
  • Peritoneal Fibrosis* / genetics
  • Peritoneum / pathology
  • Rats
  • Rats, Wistar

Substances

  • Bleomycin
  • Lansoprazole